Results from the Completed Dose-Escalation of the Hematological Arm of the Phase I Think Study Evaluating Multiple Infusions of NKG2D-Based CAR T-Cells As Standalone Therapy in Relapse/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

Violaine Havelange,Anne Flament,Philippe Lewalle,Ahmad Awada,Kunle Odunsi,Tessa Kerre,David A Sallman,Xavier Poire,Caroline Lonez,Jason B Brayer,Thomas Lequertier,Ine Moors,Eunice S Wang,Nathalie Braun,Erik Alcantar-Orozco

doi:10.1182/blood-2019-128020

Results from the Completed Dose-Escalation of the Hematological Arm of the Phase I Think Study Evaluating Multiple Infusions of NKG2D-Based CAR T-Cells As Standalone Therapy in Relapse/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

Violaine Havelange, Anne Flament + Show 13 more

Open Access

https://doi.org/10.1182/blood-2019-128020

Copy DOI

Journal: Blood	Publication Date: Nov 13, 2019
Citations: 21

Affiliation: Cliniques Universitaires Saint-Luc, Celyad (Belgium), Institut Jules Bordet, Université Libre de Bruxelles, Roswell Park Cancer Institute, Ghent University Hospital, Moffitt Cancer Center

#Speakers Bureau #Acute Myeloid Leukemia Pts + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Results from the Completed Dose-Escalation of the Hematological Arm of the Phase I Think Study Evaluating Multiple Infusions of NKG2D-Based CAR T-Cells As Standalone Therapy in Relapse/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients

Full Text